Community Academic Profiles

Thomas Charles Merigan M.D.

Publication Details

  • Alpha interferon administration to infants with congenital rubella.

    Arvin AM, Schmidt NJ, Cantell K, Merigan TC. Antimicrob Agents Chemother. 1982; 21 (2): 259-61

    Three infants with congenital rubella syndrome were given human leukocyte (alpha) interferon at doses of 2 x 10(5) to 7 X 10(5) U/kg per day for 10 days. A transient decrease in pharyngeal virus excretion was observed with treatment. No significant side effects were associated with the administration of human leukocyte interferon to these infants.

    PubMedID: 6176183

Stanford Medicine Resources:

Footer Links: